Hypoglycemic and antioxidant effects of leaf essential oil of Pelargonium graveolens L'Hér. in alloxan induced diabetic rats

Lipids Health Dis. 2012 Jun 26;11:81. doi: 10.1186/1476-511X-11-81.

Abstract

Background: Rose-scented geranium (Pelargonium graveolens L'Hér.), which is used in traditional Tunisian folk medicine for the treatment of hyperglycaemia, is widely known as one of the medicinal herbs with the highest antioxidant activity. The present paper is conducted to test the hypoglycemic and antioxidative activities of the leaf essential oil of P. graveolens.

Methods: The essential oil P. graveolens was administered daily and orally to the rats at two doses of 75 mg/kg and 150 mg/kg body weight (b.w.) for 30 days. The chemical composition of P. graveolens essential oil, body weight, serum glucose, hepatic glycogen, thiobarbituric acid-reactive substances (TBARS), the components of hepatic, and renal and serum antioxidant systems were evaluated. The hypoglycemic effect of rose-scented geranium was compared to that of the known anti-diabetic drug glibenclamide (600 μg/kg b.w.).

Results: After the administration of two doses of essential oil of Pelargonium graveolens L'Hér. together with glibenclamide which is known by its antidiabetic activities and used as reference (600 μg/kg b.w.), for four weeks, the serum glucose significantly decreased and antioxidant perturbations were restored. The hypoglycemic effect of P. graveolens at the dose of 150 mg/kg b.w. was significantly (p < 0.05) more effective than that of glibenclamide. It is through the histological findings in hepatic and renal tissues of diabetic rats that these beneficial effects of geranium oils were confirmed.

Conclusions: It suggests that administration of essential oil of P. graveolens may be helpful in the prevention of diabetic complications associated with oxidative stress. Our results, therefore, suggest that the rose-scented geranium could be used as a safe alternative antihyperglycemic drug for diabetic patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alloxan
  • Animals
  • Antioxidants / administration & dosage*
  • Antioxidants / isolation & purification
  • Blood Glucose
  • Catalase / metabolism
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / metabolism
  • Glutathione Peroxidase / metabolism
  • Glyburide / therapeutic use
  • Glycogen / metabolism
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / isolation & purification
  • Kidney / drug effects
  • Kidney / metabolism
  • Kidney / pathology
  • Liver / drug effects
  • Liver / enzymology
  • Liver / metabolism
  • Male
  • Oils, Volatile / administration & dosage*
  • Oils, Volatile / isolation & purification
  • Pelargonium / chemistry*
  • Plant Leaves / chemistry*
  • Rats
  • Superoxide Dismutase / metabolism
  • Thiobarbituric Acid Reactive Substances / metabolism

Substances

  • Antioxidants
  • Blood Glucose
  • Hypoglycemic Agents
  • Oils, Volatile
  • Thiobarbituric Acid Reactive Substances
  • Alloxan
  • Glycogen
  • Catalase
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Glyburide